Skip to Main Content

Dear friends of WARMTH,

As my first letter as the President of WARMTH, I would like to thank the WARMTH community for this honour and privilege; I am truly humbled. I cherish this trust, and I acknowledge my need for your help to pursue excellence in using targeted radiopharmaceuticals in imaging and therapy.


Prof Partha Choudhury, the Immediate Past President, I thank you for your considerable contributions and milestones achieved under your leadership, despite the Covid-19 challenges. I am looking forward to your continued support. I am thankful to the previous Governing & Executive Boards with the guidance of the then Immediate Past President, Prof Irene Virgolini, for the collective leadership that ensured that we continue to be an influential WARMTH family. It will be remiss not to thank WARMTH's Past Presidents and friends, Prof Richard Baum, Prof Suresh Srivastava, Prof Harvey Turner, for the wisdom and foundation for WARMTH. Importantly we should keep the vision of the Founding President, Prof Ajit Padhy, alive. We will eternally miss you Ajit.

I also wish to express appreciation for the support we receive from our Chief Operating Officer, Josh Mailman. Thanks, and appreciation for our Editor in Chief, Qaisar Siraj, assisted by the Governing Board for publishing the first edition of the WJNM under the new publisher, Thieme. We are looking forward to publishing more manuscripts in a faster and smoother process.

Friends, I am excited to announce the new Governing Body and Executive Body of WARMTH for the 2022/3 term.


Executive Board:

Governing Body:

Kalevi Kairemo (FI) – President-elect (2024-5) Hojjat Amadzadehfar (DE)
Mariela Agolti (AR)- Secretary Anca Avram (USA)
Aviral Singh (AU) – Treasurer Batool Al Balooshi (UAE)
Josh Mailman (USA) - COO Gopinath Gnanasegaran (UK)
Partha Choudhury (IN)- Immediate Past President Raihan Hussain (BD)
Irene Virgolini (AT) – At large Member Sze Ting Lee (AU)
  Masha Maharaj (SA)
Qaisar Siraj (KU) – EIC WJNM Raluca Mititelu (RO)


Congratulations to all of you. We are so thankful to have this formidable Governing Body as we collectively create new opportunities for Members of WARMTH. To the President-Elect, Kalevi Kairemo, well done on a position well-deserved. We can't wait for your valuable input.

Colleagues and friends, WARMTH will continue its collaboration and national societies and strengthen the partnerships that may help offer growth opportunities with other regional and international organizations (IAEA, ICPO, WFNMB, SNMMI, EANM, AOFNMB, AANM, ARSNM, ALASBIMN). In this regard, we will resume the joint SNMMI and WARMTH sessions in the Continuing Medical Education program during the SNMMI Annual Meeting in Vancouver, 2022. Furthermore, we are looking forward to our ICRT during the 13th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) 2022 in Kyoto, Japan. We encourage many of our members to attend and participate in these events face-to-face. Together with the IAEA, we are looking forward to our face-to-face ISRT in May 2023. There will be several webinars and teaching opportunities that we will hold in between our face-to-face meetings. Our first webinar will celebrate World Theragnostics Day, entitled "Theragnostics using 177Lu-PSMA for Prostate cancer patients". Thanks the two leading experts, Prof Louise Emmett and Prof Oliver Sartor.

We will continue with our current scientific projects (Thyroid Diseases, PRRT for NETS, and PRLT with 177Lu-PSMA for Prostate cancer) and introduce two new projects, namely, PRLT with 225Ac-PSMA and reviving the use of 188Re, e.g., Liver cancer and Breast cancer.

We must work together to clearly articulate the value of radio-theragnotics, which should impact the lives of our patients and health care delivery and define well our career as nuclear physicians.

I trust that this is a remarkable time for WARMTH to be innovative.


Mike Sathekge
President WARMTH